[D-Phe12]-Bombesin

CAS No. 108437-87-2

[D-Phe12]-Bombesin( ——— )

Catalog No. M42097 CAS No. 108437-87-2

[D-Phe12]-Bombesin is a derivative of Bombesin and an antagonist for bombesin receptor with Ki of 4.7 μM. [D-Phe12]-Bombesin inhibits the Bombesin -induced amylase release, with IC50 of 4 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 423 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    [D-Phe12]-Bombesin
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Phe12]-Bombesin is a derivative of Bombesin and an antagonist for bombesin receptor with Ki of 4.7 μM. [D-Phe12]-Bombesin inhibits the Bombesin -induced amylase release, with IC50 of 4 μM.
  • Description
    Bombesin receptor antagonist
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Bombesin receptor
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    108437-87-2
  • Formula Weight
    1629.88
  • Molecular Formula
    C74H112N22O18S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Heinz-Erian P, et al., D-Phe12bombesin analogues: a new class of bombesin receptor antagonists. Am J Physiol. 1987 Mar;252(3 Pt 1):G439-42. ?
molnova catalog
related products
  • Sulfamethoxypyridazi...

    Sulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.

  • Acitemate

    Acitemate(Chinoin 123) has an inhibitory effect on atherosclerosis and reduces the permeability of the aorta in rabbits fed a hyperlipidemic diet, which can be used to study atherosclerosis.

  • 8-Hydroxypinoresinol...

    8-Hydroxypinoresinol diglucoside is a natural product for research related to life sciences.